Selected strategies to fight pathogenic bacteria

A Plotniece, A Sobolev, CT Supuran… - Journal of enzyme …, 2023 - Taylor & Francis
Natural products and analogues are a source of antibacterial drug discovery. Considering
drug resistance levels emerging for antibiotics, identification of bacterial metalloenzymes …

Carbonic anhydrase inhibitors as novel antibacterials in the era of antibiotic resistance: where are we now?

A Nocentini, C Capasso, CT Supuran - Antibiotics, 2023 - mdpi.com
Resistance to antibiotic treatment developed by bacteria in humans and animals occurs
when the microorganisms resist treatment with clinically approved antibiotics. Actions must …

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae

NS Abutaleb, AEM Elhassanny… - Journal of Enzyme …, 2022 - Taylor & Francis
Neisseria gonorrhoeae is a high-priority pathogen of concern due to the growing prevalence
of resistance development against approved antibiotics. Herein, we report the anti …

[HTML][HTML] Mucoadhesive brinzolamide-loaded nanofibers for alternative glaucoma treatment

O Cegielska, M Sierakowski, P Sajkiewicz… - European Journal of …, 2022 - Elsevier
Despite the advances in the field of pharmaceutical materials and technology, topical
administration remains a method of choice for the treatment of eye diseases such as …

Coumarins effectively inhibit bacterial α-carbonic anhydrases

S Giovannuzzi, CS Hewitt, A Nocentini… - Journal of Enzyme …, 2022 - Taylor & Francis
Coumarins are known to act as prodrug inhibitors of mammalian α-carbonic anhydrases
(CAs, EC 4.2. 1.1) but they were not yet investigated for the inhibition of bacterial α-CAs …

Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships

M Fantacuzzi, I D'Agostino, S Carradori… - Journal of Enzyme …, 2023 - Taylor & Francis
Vibrio cholerae causes life-threatening infections in low-income countries due to the rise of
antibacterial resistance. Innovative pharmacological targets have been investigated and …

Development of Penicillin-Based Carbonic Anhydrase Inhibitors Targeting Multidrug-Resistant Neisseria gonorrhoeae

A Bonardi, A Nocentini, S Giovannuzzi… - Journal of Medicinal …, 2024 - ACS Publications
The development of antibacterial drugs with new mechanisms of action is crucial in
combating the rise of antibiotic-resistant infections. Bacterial carbonic anhydrases (CAs, EC …

Inhibition of pathogenic bacterial carbonic anhydrases by monothiocarbamates

S Giovannuzzi, AK Marapaka, NS Abutaleb… - Journal of Enzyme …, 2023 - Taylor & Francis
Carbonic anhydrases (CAs) from the pathogenic bacteria Nesseria gonorrhoeae and
vancomycin-resistant enterococci (VRE) have recently been validated as antibacterial drug …

Evaluation of 1, 3, 4-thiadiazole carbonic anhydrase inhibitors for gut decolonization of vancomycin-resistant enterococci

NS Abutaleb, A Shrinidhi, AB Bandara… - ACS Medicinal …, 2023 - ACS Publications
Vancomycin-resistant enterococci (VRE), Enterococcus faecium and Enterococcus faecalis,
are high-priority drug-resistant pathogens in need of new therapeutic approaches. VRE …

Biological investigation of N-methyl thiosemicarbazones as antimicrobial agents and bacterial carbonic anhydrases inhibitors

I D'Agostino, GE Mathew, P Angelini… - Journal of Enzyme …, 2022 - Taylor & Francis
The enormous burden of the COVID-19 pandemic in economic and healthcare terms has
cast a shadow on the serious threat of antimicrobial resistance, increasing the inappropriate …